Your browser doesn't support javascript.
loading
The impact of duration and severity of obesity exposure on cardiometabolic health.
van Ede, Elisabeth S; Nienhuijs, Simon W; Goossens, Gijs H; Bouwman, R Arthur; Buise, Marc P.
Afiliação
  • van Ede ES; Department of Anesthesiology, Catharina Hospital, 5623 EJ, Eindhoven, the Netherlands. lisavanede@hotmail.nl.
  • Nienhuijs SW; Department of Electrical Engineering, Signal Processing Systems, Eindhoven University of Technology, 5600 MB, Eindhoven, The Netherlands. lisavanede@hotmail.nl.
  • Goossens GH; Department of Surgery, Catharina Hospital, 5623 EJ, Eindhoven, the Netherlands.
  • Bouwman RA; Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, 6200 MD, Maastricht, the Netherlands.
  • Buise MP; Department of Anesthesiology, Catharina Hospital, 5623 EJ, Eindhoven, the Netherlands.
Obes Surg ; 34(7): 2587-2595, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38833133
ABSTRACT

PURPOSE:

Duration and severity of exposure to excess adipose tissue are important risk factors for complications, but are generally not examined in conjunction. We developed a metric considering both factors to examine the relationship between obesity-related complications and parameters of cardiometabolic health in patients undergoing a metabolic bariatric procedure (MBS). MATERIALS &

METHODS:

Data from patients screened for primary MBS between 2017 and 2021 were analyzed. The Obesity Exposure score (OBES), based on self-reported years of life with a BMI ≥ 25 kg/m2, was calculated with increased weighting applied for higher BMI categories. Multivariate logistic regression analysis was performed, adjusting for multiple potential confounders.

RESULTS:

In total, 2441 patients were included (76% female, age 42.1 ± 11.9 years, BMI 42.0 ± 4.9 kg/m2). OBES was positively related to myocardial infarction, atrial fibrillation and renal function loss (per 10 OBES-units OR 1.31, 95%CI [1.11-1.52], p = 0.002; OR 1.23, 95% CI [1.06-1.44], p = 0.008; and OR 1.26, 95% CI [1.04-1.51], p = 0.02). OBES was negatively associated with obstructive sleep apnea syndrome (OSAS) (OR 0.90, 95% CI [0.83-0.98], p = 0.02). In patients without obesity-related complications, OBES was related to lower HbA1c and higher HDL-cholesterol levels (ß -0.5 95% CI [-0.08-.0.02] p < 0.001 and ß 0.02 [0.00-0.04] p = 0.01).

CONCLUSION:

OBES was related to myocardial infarction, atrial fibrillation and renal function loss in patients applying for MBS. OBES was negatively related to OSAS, possibly because undiagnosed years were not taken into account. In the absence of obesity-related complications, OBES was not related to metabolic blood markers. Our data may aid in improving perioperative risk assessments.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Obesidade Mórbida Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Obes Surg Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Obesidade Mórbida Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Obes Surg Ano de publicação: 2024 Tipo de documento: Article